Bafna Pharmaceuticals Ltd.

•

bafnapharma.comBSE: 532989NSE: BAFNAPH

Market Cap₹ 717 Cr.

Current Price

High / Low₹ 318 / 95

Stock P/E—

Book Value—

Price to Book—

Dividend Yield0.00 %

ROCE-3.0 %

ROE-25.4 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Operating margins have improved to 3.5% from -7.0%
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.13x)
Company generates healthy free cash flow

CONS

Company is loss-making at the operating / net level
Company has a low return on equity of -45.8% over last 3 years
Operating cash flow has been negative in recent years
Company has a low return on capital employed of -10.7%
Interest coverage is weak at -18.7x - earnings barely cover interest
Promoter holding has decreased over last 2 years: -13.3pp

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1842.00	36.54	441957.50	0.87	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9326.00	84.64	247576.00	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4975.00	86.76	189233.01	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1119.50	24.74	111670.55	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1365.00	32.72	110272.68	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1970.35	97.37	106460.42	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	DRREDDY	1161.00	30.07	96906.38	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
8.	AUROPHARMA	1675.45	25.97	96401.69	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
9.	LUPIN	2096.00	17.34	95842.92	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2277.00	46.04	94050.37	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2416.90	37.94	68210.88	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	BAFNAPH	303.00	92.04	716.79	0.00	6.04	—	131.33	—	11.87	32.32

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2020
	131
	94
Operating Profit	37
OPM %	28.13%
	2
Interest	0
Depreciation	5
Profit before Tax	22
Tax %	72.32%
Net Profit	6
	0.20

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
	129	176	185	139	85	65	47	44	42
	110	153	162	115	85	71	82	57	41
Operating Profit	19	22	23	23	1	-6	-35	-13	1
OPM %	14.50%	12.79%	12.33%	16.90%	0.61%	-8.94%	-74.48%	-29.97%	2.88%
	1	3	2	2	2	1	31	0	0
Interest	8	12	13	13	13	11	7	2	0
Depreciation	6	8	9	6	5	4	4	3	3
Profit before Tax	5	5	2	6	-15	-20	-15	-18	-2
Tax %	64.53%	26.93%	42.02%	-2.51%	1.16%	4.43%	-14.90%	-5.84%	-0.00%
Net Profit	2	4	1	6	-15	-19	-17	-19	-2
EPS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Payout %	0.00%	28.25%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: -21%
3 Years:: -13%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: —
5 Years:: 19%
3 Years:: 48%
1 Year:: 170%

RETURN ON EQUITY

10 Years:: —
5 Years:: -40%
3 Years:: -46%
Last Year:: -25%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
Equity Capital	18	19	19	19	19	19	24	24	2
Minority Interest	1	1	1	1	-0	-1	-1	-0	0
	40	46	50	53	39	20	14	-5	-7
	86	101	110	69	81	95	59	47	3
Trade Payables	58	79	42	42	38	24	29	40	13
	15	15	15	16	16	21	13	14	60
Total Liabilities	219	261	236	200	193	178	138	119	71
	76	73	69	55	53	49	45	37	35
	0	0	0	17	17	17	0	0	0
	24	22	27	16	16	17	11	9	11
	0	0	0	0	0	0	0	0	0
Cash & Bank	2	21	3	3	3	3	3	3	8
	116	144	136	109	104	93	80	70	16
Total Assets	219	261	236	200	193	178	138	119	71

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
	30	38	2	13	1	-1	-7	-2	-34
Cash from Investing	-38	-6	-7	60	-0	-5	38	15	33
Cash from Financing	-1	-12	-13	-71	-1	6	-31	-14	7
	-9	19	-18	-0	-0	-0	0	-0	6

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	88.30	88.30	88.30	75.00	75.00	75.00	75.00	75.00	75.00
	0.00	0.00	0.00	8.53	9.34	9.34	9.34	9.34	9.34
DIIs	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	11.70	11.70	11.70	16.47	15.66	15.66	15.66	15.66	15.66

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-11

Shareholders meeting

2026-09-11 - Bafna Pharmaceuticals Limited has submitted to the Exchange Voting Results of the 31st Annual General Meeting of the Company held on September 11, 2026 along with the Scrutinizer Report.

2026-09-11

Shareholders meeting

2026-09-11 - Bafna Pharmaceuticals Limited has informed the Exchange regarding Proceedings of the 31st Annual General Meeting of the Company held on September 11, 2026

2026-08-21

Copy of Newspaper Publication

2026-08-21 - Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication for the 31st Annual General Meeting of the Company published in ''Business Standard'' and ''Makkal Kural'' on August 20, 2026

2026-08-19

Shareholders meeting

2026-08-19 - Bafna Pharmaceuticals Limited has informed the Exchange regarding Notice of 31st Annual General Meeting of the Company to be held on September 11, 2026 along with the Annual Report for F.Y 2025-2026

2026-08-14

Copy of Newspaper Publication

2026-08-14 - Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication for the Unaudited Financial Results of the Company for the Quarter ended June 30, 2026 as published in ''Business Standard'' and ''Makkal Kural'' on August 13, 2026

2026-08-13

Updates

2026-08-13 - Bafna Pharmaceuticals Limited has informed the Exchange regarding 'Intimation for Book Closure & Cut off Date'.

2026-08-13

Shareholders meeting

2026-08-13 - Bafna Pharmaceuticals Limited has informed the Exchange regarding intimation for 31st Annual General Meeting of the Company to be held on September 11, 2026

2026-08-11

Outcome of Board Meeting

2026-08-11 - Bafna Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 11, 2026.

2026-08-11

Outcome of Board Meeting

2026-08-11 - Bafna Pharmaceuticals Limited has submitted to the Exchange, the outcome of the Board Meeting held on 11/08/2026 along with the unaudited financial results for the quarter ended June 30, 2026.

News

Recent coverage and analyst commentary for BAFNAPH

Loading news…

🤖

AI Stock Analyst

Bafna Pharmaceuticals Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1842.00

36.54

441957.50

0.87

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9326.00

84.64

247576.00

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4975.00

86.76

189233.01

0.76

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1119.50

24.74

111670.55

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1365.00

32.72

110272.68

0.95

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1970.35

97.37

106460.42

0.10

362.07

123.94

2026.31

29.10

18.20

31.50

DRREDDY

1161.00

30.07

96906.38

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1675.45

25.97

96401.69

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

LUPIN

2096.00

17.34

95842.92

0.86

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2277.00

46.04

94050.37

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

GLENMARK

2416.90

37.94

68210.88

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

BAFNAPH

303.00

92.04

716.79

0.00

6.04

—

131.33

—

11.87

32.32

Mar 2020

131

Operating Profit

OPM %

28.13%

Interest

Depreciation

Profit before Tax

Tax %

72.32%

Net Profit

0.20

Mar 2012

Mar 2013

Mar 2014

Mar 2015

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

129

176

185

139

110

153

162

115

Operating Profit

-6

-35

-13

OPM %

14.50%

12.79%

12.33%

16.90%

0.61%

-8.94%

-74.48%

-29.97%

2.88%

Interest

Depreciation

Profit before Tax

-15

-20

-15

-18

-2

Tax %

64.53%

26.93%

42.02%

-2.51%

1.16%

4.43%

-14.90%

-5.84%

-0.00%

Net Profit

-15

-19

-17

-19

-2

EPS

0.00

Dividend Payout %

0.00%

28.25%

0.00%

Mar 2012

Mar 2013

Mar 2014

Mar 2015

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Equity Capital

Minority Interest

-0

-1

-0

-5

-7

101

110

Trade Payables

Total Liabilities

219

261

236

200

193

178

138

119

Cash & Bank

116

144

136

109

104

Total Assets

219

261

236

200

193

178

138

119

Mar 2012

Mar 2013

Mar 2014

Mar 2015

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

-1

-7

-2

-34

Cash from Investing

-38

-6

-7

-0

-5

Cash from Financing

-1

-12

-13

-71

-1

-31

-14

-9

-18

-0

Mar 2012

Mar 2013

Mar 2014

Mar 2015

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

88.30

75.00

0.00

8.53

9.34

DIIs

0.00

Government

0.00

11.70

16.47

15.66

Bafna Pharmaceuticals Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Bafna Pharmaceuticals Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI